by Jacques Lemoisson | Jan 11, 2021
11 million people are in containment in China as of today, pandemic figures in the USA are skyrocketing and the EU is managing logistical issues. As written in the Lancet report, at 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue...
by Jacques Lemoisson | Jan 1, 2021
Mistrust about vaccines is spreading fast… I pointed out this issue in my outlook, as a major one. The gap of temporality between markets’ assumptions and the reality will become too wide. Slow vaccines adoption will postpone the full recovery. Nursing home...
by Jacques Lemoisson | Dec 29, 2020
As usual, the goal of this document is to propose answers to the main questions over 2021. Global economic growth: Rapid catch up (effective vaccines?) or “Groundhog Day” infection? Biden: Post-Trump Era complete shift or simple transition? The USA is back in the...
by Jacques Lemoisson | Dec 22, 2020
Like in other countries, between 40% to 50% in the USA is not comfortable with Moderna/Pfizer vaccines. Politicians need to demonstrate their confidence in these vaccines by publically trying first! In the end, the biggest “nursing homes” in all countries...
by Jacques Lemoisson | Dec 21, 2020
In addition, in the event of large cold waves, “very short cuts” of electricity were now envisaged in France this winter. Why? 1 – The electricity sector in France is dominated by nuclear power (70%). Due to the Covid, EDF, the main French electricity producer,...